Akari Therapeutics Plc

Ownership Transactions Reported by 8 Insiders

Symbol
AKTX on Nasdaq
Location
22 Boston Wharf Road, Fl 7, Boston, MA

There are no Buy or Sell transactions made by insiders since 11/5/2023

Akari Therapeutics Plc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Robert B. Bazemore Director Sep 17, 2024
Wendy F. Dicicco Interim CFO May 1, 2024
Michael Grissinger Director Jun 28, 2024
Samir Rashmikant Patel Director Oct 31, 2024
Donald A. Williams Director Jun 28, 2024
Raymond Prudo-Chlebosz Director Jun 28, 2024
Rachelle Suzanne Jacques Chief Executive Officer, Director Apr 26, 2024
Mohamed Wa'el Ahmed Hashad Director Jun 28, 2024

Recent Insider Transactions by Companies or Individuals for Akari Therapeutics Plc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.